Publication | Open Access
A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot–Marie–Tooth disease type 1A
50
Citations
61
References
2020
Year
A novel HDAC6 inhibitor, CKD-504, has potent therapeutic efficacy for CMT1A.
| Year | Citations | |
|---|---|---|
Page 1
Page 1